Civic Intelligence

Global Health Solutions Inc

EIN 20-3674498 • 501(c)3 • Decatur, GA

Profile

As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and shipping them to designated countries for the treatment of blinding trachoma, river blindness and vaccine preventable diseases.

330 W Ponce de Leon AveDecatur, GA 30030-3001

www.taskforce.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2024

Liabilities / Revenue

2nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • $250M-$1B nonprofits • Source year 2024

Net Margin

33rd percentile

0.0%

Higher net margin than 33% of similar nonprofits.

501(c)3 • $250M-$1B nonprofits • Source year 2024

Top Officer Pay

20th percentile

$411,644

Higher top officer pay than 20% of similar nonprofits.

Top officer pay equals 0.1% of source-year revenue.

501(c)3 • $250M-$1B nonprofits • Source year 2024

Asset Growth

Score unavailable

No value available

A valid growth rate could not be computed from the available filing history.

Annualized from 2023 to 2024

Revenue Growth

7th percentile

-19%

Faster revenue growth than 7% of similar nonprofits.

501(c)3 • $250M-$1B nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Flat

$0

Flat from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Flat

$0

Flat from 2023

Operations
Liabilities / Revenue2nd percentileNet Margin33rd percentile

Revenue

Down

$511,468,181

Down $117,340,885 (-19%) from 2023

Expenses

Down

$511,468,181

Down $117,340,885 (-19%) from 2023

Net Income

Flat

$0

Flat from 2023

Trend Graphs

Balance Sheet Trend

Asset GrowthScore unavailable

Grouped bars show assets, liabilities, and net assets across loaded filings.

$3.0M$2.0M$1.0M$0Assets 2010: $2,355,762Liabilities 2010: $0Net Assets 2010: $2,355,7622010Assets 2011: $2,355,057Liabilities 2011: $0Net Assets 2011: $2,355,0572011Assets 2012: $2,354,867Liabilities 2012: $0Net Assets 2012: $2,354,8672012Assets 2013: $2,354,585Liabilities 2013: $0Net Assets 2013: $2,354,5852013Assets 2014: $2,354,303Liabilities 2014: $0Net Assets 2014: $2,354,3032014Assets 2015: $2,354,008Liabilities 2015: $0Net Assets 2015: $2,354,0082015Assets 2016: $0Liabilities 2016: $0Net Assets 2016: $02016Assets 2017: $0Liabilities 2017: $0Net Assets 2017: $02017Assets 2018: $0Liabilities 2018: $0Net Assets 2018: $02018Assets 2019: $0Liabilities 2019: $0Net Assets 2019: $02019Assets 2020: $0Liabilities 2020: $0Net Assets 2020: $02020Assets 2021: $0Liabilities 2021: $0Net Assets 2021: $02021Assets 2022: $0Liabilities 2022: $0Net Assets 2022: $02022Assets 2023: $0Liabilities 2023: $0Net Assets 2023: $02023Assets 2024: $0Liabilities 2024: $0Net Assets 2024: $02024

Highlighted filing

2024

Assets$0
Liabilities$0
Net Assets$0
Open 2024 Filing

Operations Trend

Revenue Growth7th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$4.0B$3.0B$2.0B$1.0B$0-$1.0BExpenses 2010: $1,120,650,0812010Expenses 2011: $1,131,365,2102011Expenses 2012: $1,634,124,1552012Revenue 2013: $1,574,497,941Expenses 2013: $1,574,498,224Net Income 2013: -$2832013Revenue 2014: $1,790,885,365Expenses 2014: $1,790,885,647Net Income 2014: -$2822014Revenue 2015: $1,609,270,608Expenses 2015: $1,609,270,903Net Income 2015: -$2952015Revenue 2016: $3,126,468,204Expenses 2016: $3,128,822,213Net Income 2016: -$2,354,0092016Revenue 2017: $2,619,112,431Expenses 2017: $2,619,112,431Net Income 2017: $02017Revenue 2018: $2,143,738,652Expenses 2018: $2,143,738,652Net Income 2018: $02018Revenue 2019: $2,522,088,710Expenses 2019: $2,522,088,710Net Income 2019: $02019Revenue 2020: $846,866,932Expenses 2020: $846,866,932Net Income 2020: $02020Revenue 2021: $961,202,345Expenses 2021: $961,202,345Net Income 2021: $02021Revenue 2022: $632,371,996Expenses 2022: $632,371,996Net Income 2022: $02022Revenue 2023: $628,809,066Expenses 2023: $628,809,066Net Income 2023: $02023Revenue 2024: $511,468,181Expenses 2024: $511,468,181Net Income 2024: $02024

Highlighted filing

2024

Revenue$511,468,181
Expenses$511,468,181
Net Income$0
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Facts available. Structured filing facts are available, but richer extracted sections are limited.

Open filing
Assets
$0
Liabilities
$0
Net assets
$0
Revenue
$511,468,181
Expenses
$511,468,181
Net income
$0
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.00$0.00$0.00$511$511$0.00
2023Summary only. Only limited summary data is available for this year.$0.00$0.00$0.00$629$629$0.00
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.00$0.00$632$632$0.00
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.00$0.00$0.00$961$961$0.00
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.00$0.00$847$847$0.00
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.00$0.00$2,522$2,522$0.00
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.00$0.00$0.00$2,144$2,144$0.00
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.00$0.00$0.00$2,619$2,619$0.00
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.00$0.00$3,126$3,129$2.35
2015Summary only. Only limited summary data is available for this year.$2.35$0.00$2.35$1,609$1,609$0.00
2014Detailed filing. Detailed filing data is available for this year.$2.35$0.00$2.35$1,791$1,791$0.00
2013Summary only. Only limited summary data is available for this year.$2.35$0.00$2.35$1,574$1,574$0.00
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.35$0.00$2.35$1,634
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.36$0.00$2.36$1,131
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.36$0.00$2.36$1,121
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Sep 1, 2023 to Aug 31, 2024
Signed
Apr 30, 2025
Return Version
2023v6.0
Gross Receipts
$511,468,181
Mission and Program Overview

Mission

As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and shipping them to designated countries for the treatment of bliniding trachoma, river blindness and intestinal worms in children.

As a supporting organization, provide support to the global health initiatives of The Task Force for Global Health,Inc.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$0$0→ $0
Savings and Temporary Cash Investments$0$0→ $0
Accounts Receivable$0$0→ $0
Other Notes and Loans Receivable, Net$0$0→ $0
Pledges and Grants Receivable$0$0→ $0
Receivable From Disqualified Prsn$0$0→ $0
Receivables From Officers Etc$0$0→ $0
Investments Other Securities$0$0→ $0
Investments Program Related$0$0→ $0
Investments in Publicly Traded Securities$0$0→ $0
Intangible Assets$0$0→ $0
Inventories for Sale or Use$0$0→ $0
Loans From Officers Directors$0$0→ $0
Prepaid Expenses and Deferred Charges$0$0→ $0
Other Assets Total$0$0→ $0
Total Assets$0$0→ $0
Liabilities
Accounts Payable and Accrued Expenses$0$0→ $0
Grants Payable$0$0→ $0
Mortgage Notes Payable Secured by Investment Property$0$0→ $0
Unsecured Notes Loans Payable$0$0→ $0
Other Liabilities$0--
Deferred Revenue$0$0→ $0
Escrow Account Liability$0$0→ $0
Tax Exempt Bond Liabilities$0$0→ $0
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Net Assets With Donor Restrictions$0$0→ $0
Net Assets Without Donor Restrictions$0$0→ $0
Total Net Assets Fund Balance$0$0→ $0
Total Liabilities and Net Assets / Fund Balance$0$0→ $0
Compensation and Service Providers
Top Officer Pay20th percentile

Employees

NameTitleOtherTotal
Mark McKinlayOfficer$387,309$387,309
Daniel N MartinsSecretary$253,744$253,744
Ellen WildTreasurer$227,921$227,921

Board Members and Trustees

NameTitle
Patrick O'CarrollChairman
Mark McKinlayMember
Ellen WildOfficer
William P NicholsOfficer
Daniel N MartinsTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$511,468,181
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$511,468,181
Change in Net Assets
$0

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
Yes
Third parties used for noncash contributions
Yes

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Drugs and Medical Supplies2$511,468,181Lower of market cost or donor's cost
Total Noncash Contributions2$511,468,181-

Audited Revenue Reconciliation

Revenue per Audited Statements
$511,468,181
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$0
Total Revenue per Audited Statements
$511,468,181
Total Revenue per Form 990
$511,468,181
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$511,468,181
Other Expenses$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Foreign Grants$511,468,181--$511,468,181
Total Functional Expenses$511,468,181$0$0$511,468,181

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$511,468,181
Total Expenses per Audited Statements$511,468,181
Total Expenses per Form 990$511,468,181
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
Other Expense Adjustments$0
International Activity

International Summary

Offices
0
Employees
0
Spending
$511,468,181

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
Yes
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Sub-Saharan AfricaProgram ServicesDonation of zithromax drug for the treatment of blinding trachoma.00$441,755,152
South AsiaProgram ServicesDonation of mectizan drug for the treatment of lymphatic filariasis.00$25,009,845
Sub-Saharan AfricaProgram ServicesDonation of mectizan drug for the treatment of lymphatic filariasis.00$24,683,190
Middle East and North AfricaProgram ServicesDonation of zithromax drug for the treatment of blinding trachoma.00$11,474,201
East Asia and the PacificProgram ServicesDonation of zithromax drug for the treatment of blinding trachoma00$5,403,353
East Asia and the PacificProgram ServicesDonation of mectizan drug for the treatment of lymphatic filariasis.00$2,663,535
South AmericaProgram ServicesDonation of mectizan drug for the treatment of lymphatic filariasis.00$384,405
Central America and the CaribbeanProgram ServicesDonation of mectizan drug for the treatment of lymphatic filariasis.00$94,500
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$0$0→ $0
Receivables from Disqualified Persons$0$0→ $0
Receivables from Officers, Directors, Trustees, and Key Employees$0$0→ $0
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
No
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Once Form 990 is completed, it is emailed as a pdf file to each board member and officers for their review and comments. They are required to notify the organization with any issues or concerns they may have.”

Form 990, Part VI, Section B, Line 12C

“The organization does not have employees but has officers. At the end of every fiscal year, all officers are required to read and sign all relevant policies.”

Form 990, Part VI, Section C, Line 19

“The financial information for three fiscal years is available on the organization's website together with its Form 990 reports and conflict of interest policy.”

Filing and Contact Details

Filer

Filer Name
Global Health Solutions Inc
EIN
20-3674498
Phone
4045921430
Address
330 W Ponce de Leon Ave, Decatur, GA 30030-3001

Signing Officer

Name
Ellen Wild
Title
Chief Operating Officer
Phone
4046875607
Signed
2025-04-30

Organization Details

Principal Officer
Ellen Wild
Formed
2005
Legal Domicile
Ga
Voting Board Members
4
Independent Board Members
0
Employees
0
Volunteers
0
Supplemental Narrative

Financial Statement Notes

Schedule D, Part VI, Line 1A

“The Organization does not own any assets and does not owe any liabilities and so does not have a balance sheet.”

Raw XML AppendixShowing 400 of 631 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt00
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt00
IRS990/AccountsReceivableGrp/BOYAmt00
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0As a supporting organization, provide support to the global health initiatives of The Task Force for Global Health,Inc.
IRS990/AllOtherContributionsAmt0511468181
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd00
IRS990/BooksInCareOfDetail/PersonNm0Daniel N Martins
IRS990/BooksInCareOfDetail/PhoneNum04046875620
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0330 W Ponce de Leon Ave
IRS990/BooksInCareOfDetail/USAddress/CityNm0Decatur
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0GA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd0300303001
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt00
IRS990/CashNonInterestBearingGrp/EOYAmt00
IRS990/ChangeToOrgDocumentsInd00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContriRptFundraisingEventAmt00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0511468181
IRS990/CYGrantsAndSimilarPaidAmt0511468181
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt00
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt00
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0511468181
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0511468181
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd01
IRS990/DeferredRevenueGrp/BOYAmt00
IRS990/DeferredRevenueGrp/EOYAmt00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of azithromycin to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2023 and August 2024, ITI organized just-in-time shipments of 33.3 million treatments for trachoma to be distributed at MDAs in 15 countries. As of August 2024, ITI has shipped more than 1.073 billion treatments to trachoma-endemic countries since the program's inception in 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision-making on where antibiotic treatments are needed and where they can be stopped. Since its inception in February 2016, Tropical Data has supported over 3,823 surveys across 52 countries. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.2 billion people in 2000 to 103.2 million in April 2024 according to the World Health Organization's (WHO) Weekly Epidemiological Record (WER). ITI will continue to work smarter so that the dream of a trachoma-free world becomes a reality.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonatedServicesAndUseFcltsAmt00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt00
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/EscrowAccountLiabilityGrp/BOYAmt00
IRS990/EscrowAccountLiabilityGrp/EOYAmt00
IRS990/ExpenseAmt0458632706
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditPerformedInd01
IRS990/FederalGrantAuditRequiredInd01
IRS990/FederatedCampaignsAmt00
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0511468181
IRS990/ForeignGrantsGrp/TotalAmt0511468181
IRS990/ForeignOfficeInd00
IRS990/Form1098CFiledInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form8899Filedind00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt039
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt139
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt239
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt339
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt439
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41
IRS990/Form990PartVIISectionAGrp/FormerOfcrDirectorTrusteeInd0X
IRS990/Form990PartVIISectionAGrp/FormerOfcrDirectorTrusteeInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/PersonNm0Patrick O'Carroll
IRS990/Form990PartVIISectionAGrp/PersonNm1Mark McKinlay
IRS990/Form990PartVIISectionAGrp/PersonNm2William P Nichols
IRS990/Form990PartVIISectionAGrp/PersonNm3Daniel N Martins
IRS990/Form990PartVIISectionAGrp/PersonNm4Ellen Wild
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt0411644
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt1387309
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt2339114
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt3253744
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt4227921
IRS990/Form990PartVIISectionAGrp/TitleTxt0Chairman
IRS990/Form990PartVIISectionAGrp/TitleTxt1Officer
IRS990/Form990PartVIISectionAGrp/TitleTxt2Officer
IRS990/Form990PartVIISectionAGrp/TitleTxt3Secretary
IRS990/Form990PartVIISectionAGrp/TitleTxt4Treasurer
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02005
IRS990/FormerOfcrEmployeesListedInd01
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/FundraisingAmt00
IRS990/GainOrLossGrp/OtherAmt00
IRS990/GainOrLossGrp/SecuritiesAmt00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GovernmentGrantsAmt00
IRS990/GrantAmt00
IRS990/GrantsPayableGrp/BOYAmt00
IRS990/GrantsPayableGrp/EOYAmt00
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt0511468181
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt00
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartVIInd0X
IRS990/IntangibleAssetsGrp/BOYAmt00
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InventoriesForSaleOrUseGrp/BOYAmt00
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentExpenseAmt00
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt00
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt00
IRS990/InvestmentsPubTradedSecGrp/EOYAmt00
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0GA
IRS990/LoanOutstandingInd00
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt00
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembershipDuesAmt00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and coordinating the shipment to designated countries for the treatment of blinding trachoma, river blindness and vaccine preventable diseases.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/MortgNotesPyblScrdInvstPropGrp/BOYAmt00
IRS990/MortgNotesPyblScrdInvstPropGrp/EOYAmt00
IRS990/NetAssetsOrFundBalancesBOYAmt00
IRS990/NetAssetsOrFundBalancesEOYAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt00
IRS990/NoncashContributionsAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt00
IRS990/OtherAssetsTotalGrp/EOYAmt00
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherLiabilitiesGrp/BOYAmt00
IRS990/OtherRevenueTotalAmt00
IRS990/OthNotesLoansReceivableNetGrp/BOYAmt00
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt00
IRS990/OwnWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt00
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt00
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt00
IRS990/PrincipalOfficerNm0Ellen Wild
IRS990/PriorPeriodAdjustmentsAmt00
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0Mectizan Donation Program Accomplishments In 2024, 406.1 million Mectizan treatments were approved for mass drug administration (MDA) for onchocerciasis and lymphatic filariasis (LF) elimination in 44 countries and territories. The breakdown of treatments approved is as follows: (a) 274.1 million for onchocerciasis only including 63 million treatments approved to implement a second round of treatment in 9 countries (Burkina Faso, DRC, Ethiopia, Ghana, Malawi, Nigeria, Tanzania, Togo, and Uganda). (b) 36.2 million for onchocerciasis & LF co-endemic communities. (c) 95.7 million for LF only, of which 52.8 million were approved for 14 countries implementing triple therapy with ivermectin, DEC, and albendazole (IDA). By the end of 2024, cumulatively, the number of Mectizan 3mg tablets shipped since the inception of the program reached 13.9 billion or 4.94 billion treatments. The 5 billionth treatment shipped will be reached in early 2025, a very exciting milestone that the Mectizan Donation Program (MDP) will celebrate with Merck & Co., Inc. and other partners working to eliminate these diseases. Timor Leste was validated by WHO for achieving the elimination of LF as a public health problem, the first country to achieve elimination using triple therapy with the WHO-recommended triple therapy strategy: ivermectin, DEC and albendazole (IDA). A press release was issued by MDP to congratulate the country. MDP supported WHO-HQ to prepare a request to be submitted to Merck for Mectizan donation to extend the donation of Mectizan for - triple therapy - or IDA (ivermectin, diethylcarbamazine, and albendazole. The application was submitted to Merck in November 2024 for consideration. MDP also supported WHO, country partners, and others in identifying challenges and creating solutions to ensure onchocerciasis and lymphatic filariasis remain on track to meet the goals established in the WHO 2021-2030 Road Map. A robust communications and advocacy plan including an annual report, social media, video production, and e-newsletter was implemented to share progress and relevant developments with partners. Our film - Eliminating Disease with Mectizan - produced in 2023 (renamed - The Pill That's Changed Millions of Lives) was entered by the producer in the 2024 Smiley Charity Awards, a high-profile award in the UK for non-profit causes. The film was selected as a finalist in the - Corporate Cause - and SDG 3 categories. The film did not win the award; however, this increased visibility for the donation of Mectizan and efforts to eliminate onchocerciasis and lymphatic filariasis.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt052835475
IRS990/ProgSrvcAccomActy2Grp/GrantAmt00
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt052835475
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0628809066
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0628809066
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt00
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt00
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt0628809066
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0628809066
IRS990/QuidProQuoContributionsInd00
IRS990/RcvblFromDisqualifiedPrsnGrp/BOYAmt00
IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReceivablesFromOfficersEtcGrp/BOYAmt00
IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt00
IRS990/ReconcilationRevenueExpnssAmt00
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt00
IRS990/RentalIncomeOrLossGrp/PersonalAmt00
IRS990/RentalIncomeOrLossGrp/RealAmt00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt0458632706
IRS990/SavingsAndTempCashInvstGrp/BOYAmt00
IRS990/SavingsAndTempCashInvstGrp/EOYAmt00
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/IRSWrittenDeterminationInd0X
IRS990ScheduleA/OtherSupportSumAmt0511468181
IRS990ScheduleA/SupportedOrganizationsCnt01
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0581698648
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd07
IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt0511468181
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt0THE TASK FORCE FOR GLOBAL HEALTH INC
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine2Txt0Type I
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/DonatedServicesAndUseFcltsAmt00
IRS990ScheduleD/DonatedServicesUseFcltsAmt00
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt0511468181
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt00
IRS990ScheduleD/InvestmentExpensesNotIncldAmt00
IRS990ScheduleD/LossesReportedAmt00
IRS990ScheduleD/NetUnrealizedGainsInvstAmt00
IRS990ScheduleD/OtherExpensesIncludedAmt00
IRS990ScheduleD/OtherExpensesNotIncludedAmt00
IRS990ScheduleD/OtherRevenueAmt00
IRS990ScheduleD/OtherRevenuesNotIncludedAmt00
IRS990ScheduleD/PriorYearAdjustmentsAmt00
IRS990ScheduleD/RecoveriesPriorYearGrantsAmt00
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt00
IRS990ScheduleD/RevenueSubtotalAmt0511468181
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0The Organization does not own any assets and does not owe any liabilities and so does not have a balance sheet.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0Schedule D, Part VI, Line 1a
IRS990ScheduleD/TotalExpensesPerForm990Amt0511468181
IRS990ScheduleD/TotalRevenuePerForm990Amt0511468181
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt0511468181
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt0511468181
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt05403353
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt111474201
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt2441755152
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt32663535
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt4384405
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt525009845
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt624683190
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt794500
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0East Asia and the Pacific
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1Middle East and North Africa
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt2Sub-Saharan Africa
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt3East Asia and the Pacific
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt4South America
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt5South Asia
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt6Sub-Saharan Africa
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt7Central America and the Caribbean
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt0Donation of zithromax drug for the treatment of blinding trachoma
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt1Donation of zithromax drug for the treatment of blinding trachoma.
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt2Donation of zithromax drug for the treatment of blinding trachoma.
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt3Donation of mectizan drug for the treatment of lymphatic filariasis.
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt4Donation of mectizan drug for the treatment of lymphatic filariasis.
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt5Donation of mectizan drug for the treatment of lymphatic filariasis.
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt6Donation of mectizan drug for the treatment of lymphatic filariasis.
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt7Donation of mectizan drug for the treatment of lymphatic filariasis.
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0Program Services
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1Program Services
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt2Program Services
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt3Program Services
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt4Program Services
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt5Program Services
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt6Program Services
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt7Program Services
IRS990ScheduleF/BoycottCountriesInd01
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt10
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt20
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt30
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt40
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt50
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/DescriptionOfNonCashAsstTxt0Mectizan drug
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/DescriptionOfNonCashAsstTxt1Drug donation - mectizan and zithromax
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/DescriptionOfNonCashAsstTxt2Donated drugs - zithromax
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/DescriptionOfNonCashAsstTxt3Drug donation - Mectizan
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/DescriptionOfNonCashAsstTxt4Drug donation - Mectizan
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/DescriptionOfNonCashAsstTxt5Drug donation - mectizan and zithromax
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt1N/A
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt2N/A
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt3N/A
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt4N/A
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt5N/A
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt094500
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt18066888
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt211474201
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt3384405
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt425009845
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt5466438342
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0Donation of mectizan drug for the treatment of lymphatic filariasis.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt1For the treatment of lymphatic filariasis and blinding trachoma.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt2For the treatment of blinding trachoma.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt3For the treatment of lymphatic filariasis.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt4For the treatment of lymphatic filariasis.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt5For the treatment of lymphatic filariasis and blinding trachoma.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0Central America and the Caribbean
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt1East Asia and the Pacific
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt2Middle East and North Africa
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt3South America
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt4South Asia
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt5Sub-Saharan Africa
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/ValuationMethodUsedDesc0Lower of market or donor's cost.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/ValuationMethodUsedDesc1Lower of market or donor's costs

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • $250M-$1B nonprofits